Management and support of patients with fibrosing interstitial lung diseases.
Tyonn Barbera, Lesley Davila, Nina M Patel
PMID 34138813WHAT IT FOUND
Suspected fibrosing ILD needs specialist referral, high-resolution CT review, and multidisciplinary discussion.
Nurse practitioners should explain prognosis, watch antifibrotic side effects, and support oxygen, rehabilitation, and education.
Key findings
01A multidisciplinary discussion led to a change in diagnosis in 40% of patients in a review of 300 Canadian ILD records, and a usual interstitial pneumonia pattern on high-resolution CT is linked to faster decline and higher mortality.
02For IPF, prompt antifibrotic therapy is recommended to slow progression, while chronic immunosuppression is not supported because prednisone, azathioprine, and N-acetylcysteine increased hospitalization and death.
03NPs should monitor patients for medication adverse effects, including diarrhea and liver enzyme elevations with nintedanib, photosensitivity and rash with pirfenidone, and infection or blood count changes with immunosuppressants.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
This is a narrative review, not an original trial or systematic review, so it does not directly test what nurse practitioners should do. The article does not describe how it searched or selected the cited evidence. Some management statements are expert recommendations, not tested interventions. Evidence for immunosuppression in ILDs other than SSc-ILD is limited. For pirfenidone in unclassifiable ILD, the primary endpoint analysis could not be completed, and secondary endpoints suggested benefit. The 40% diagnosis change comes from a review of multidisciplinary discussion records, not a randomized trial. The 6-minute walk test can be affected by comorbidities and other conditions, so its results need careful interpretation.
The easy way to misread this
Do not read this article as proof that nurse practitioner led care improves ILD outcomes. It is a narrative review and management guide, and many statements are expert recommendations or summaries of other studies.